Dia-beat-it is working on providing transformational therapies for patients with diabetes. Current therapeutics only treat the symptoms of the disease without eliminating the underlying cause of the disease. Born out of years of cutting-edge stem cell research at UCSF and seasoned by the UCSF Entrepreneurship center, Dia-beat-it aims to change the paradigm of diabetes therapeutics from that of managing the symptoms to one that offers a cure. Utilizing our revolutionary technology to produce millions of insulin producing cells from human stem cells, we have established a platform to develop novel biologics that help the patient's body regenerate and preserve its own insulin cells.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Novel anti-diabetic drugs
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):